About us

History

Director

Faculty

Fellows

Research

Advisory Committee

Bibliography

Collaboration

Seminar and Meeting

Vallee Foundation

Search

Homepage

Useful links

กก

Principal Areas of Research

 

Metallobiochemistry

 

The CBBSM has long been recognized as one of the leading contributors to present day understanding of the role of zinc in biological systems, particularly zinc metalloenzymes. Starting with the discovery of zinc in carboxypeptidase in 1954, Professor Vallee and his colleagues have made a continuous series of important findings that have become the foundations of the field of metallobiochemistry.  Today more than 300 enzymes have been found to contain zinc and many of them were identified in the CBBSM.  Fundamental contributions to instrumental analysis of zinc in biological material and techniques to avoid metal contamination were crucial for these findings and have become the hallmarks of the laboratory.  Because the physicochemical properties of zinc are not amenable to spectral investigation, the laboratory developed the highly successful and widely emulated approach of metal substitution for studying the coordination characteristics of metals in catalytic active sites.  A significant consequence of this was the recognition that active site metals have highly unusual spectral properties indicative of an "entatic" environment in which the metal is poised for catalysis.  When coupled with rapid kinetic methods spectrally active metals can be used to measure events that occur during the catalytic process.

 

In addition to carboxypeptidase, two other early zinc metalloenzyme discoveries made in the laboratory and subsequently studied in great detail were horse liver alcohol dehydrogenase and E. coli alkaline phosphatase.  Many pioneering advances were made with these systems such as the recognition that zinc can have a structural as well as catalytic role in enzymes, and that two (or more) zinc ions can cooperate to form an active site - later termed a co-catalytic site.  The work on carboxypeptidase was extended to additional metallopeptidases starting with the bacterial neutral protease, thermolysin, and later to angiotensin converting enzyme, astacin, and the matrix metalloproteinases.  As a result of this work researchers in the laboratory were the first to recognize a unique, characteristic sequence of amino acids, a signature sequence, that signalled a catalytic zinc binding site.  When structures of these proteins began to be reported, the generality of this sequence analysis was extended to include all amino acids involved in active site metal coordination and the significance of amino acid spacing was appreciated.  Later this analysis was applied to structural zinc sites in gene regulatory proteins adding zinc clusters and zinc twists to the previously recognized zinc fingers.  The work on alcohol dehydrogenase led to studies of the enzyme in human liver, which unlike the horse enzyme, was found to catalyze the oxidation of ethylene glycol.  This led to the use of ethanol for the treatment of ethylene glycol poisoning in humans, a life-saving therapeutic intervention. Further studies, based on a novel application of affinity chromatography, led to the discovery of isozymes of the human enzyme which in turn allowed identification of genetic variations in different populations, and eventually to work on the active principles in Chinese herbal medicines that deter alcohol consumption.

 

Another early discovery was metallothionein, a cysteine-rich molecule with the highest metal content of any known protein.  Based on the rationale that the chemical properties of cadmium would be closely similar to those of the related Group IIB metal zinc, metallothionein was the result of a search for a cadmium containing protein.  Remarkably, the protein, obtained from horse kidney, not only contained cadmium but also zinc and other metals as well. Subsequently, it was shown that metallothionein from fetal liver is a copper protein while that from adult liver is a zinc protein.  Almost 4000 papers on metallothionein have been published in the last 30 years yet its biological function remains unclear and is still the subject of great interest and speculation.  Since metallothionein was originally identified as a cadmium binding protein, in an era when there was great - but unfounded - speculation about the role of cadmium in hypertension, and since it was later shown to be induced in liver by injection of cadmium, it was thought to be involved in heavy metal detoxification.  This attracted a great deal of attention, particularly by environmentalists, but simultaneously diverted effort from identifying other biological functions.  It is important to emphasize that there are at least 300 different zinc metalloenzymes known and, in addition, upwards of 500 zinc finger-type proteins.   In fact, there are more zinc-containing proteins than any other type of metalloprotein and if it weren't for hemoglobin, zinc would be the most abundant trace metal in the human body.  It seems reasonable to assume that there must be a mechanism by which zinc is apportioned to these various zinc proteins in a timely and appropriate manner.  In the absence of any other candidate regulatory molecule, metallothionein has been the CBBSM's choice for this purpose.  The principal focus has been on the capacity of metallothionein to donate some or all of its metal content to newly synthesized proteins destined to become zinc metalloproteins.  Initially, this would seem an unlikely scenario given the extremely tight binding of zinc by metallothionein.  But despite its thermodynamic stability, the zinc in metallothionein is kinetically labile and this lability can be enhanced by agents that reflect the redox potential of the cell.  Given the recently proposed role for one isoform of metallothionein in neurodegenerative disease and the ever-increasing recognition of the role of zinc in gene regulation, studies on the central function of metallothionein in zinc distribution gain enormous significance.

 

Angiogenin and Angiogenesis

 

Angiogenin is a 14kDa protein that was first identified in a tumor cell conditioned medium on the basis of its ability to induce blood vessel formation.   It is a member of the ribonuclease superfamily of proteins with close structural similarity to pancreatic RNase A.  It has extremely low catalytic activity which is nevertheless essential for its biological activity.  During 1998-1999, research focused on the potential of anti-angiogenin antibodies and other antagonists to inhibit the growth of human tumors in nude mice both to demonstrate the importance of angiogenin in the early stages of tumor growth and to assess the effectiveness of these antagonists as therapeutic agents.  We also continued to explore the mechanism of action of angiogenin at the molecular and cell biological level, and to characterize the structure/function relationships of angiogenin, the protein ribonuclease inhibitor and other types of inhibitors of angiogenin.

 

Alcohol Metabolism and Daidzin

 

Daidzin, a constituent of an ancient Chinese herbal treatment (Radix puerariae) for alcohol abuse, selectively suppresses home-cage ethanol intake by Syrian golden hamsters under a two-bottle, free choice (ethanol/water) condition.  The ethanol intake suppressive (antidipsotropic) activity of daidzin and the R. puerariae extract has been confirmed by us and independently by others in golden hamsters, Wistar rats, Fawn hooded rats, and the genetically bred P rats under various experimental conditions, including two-lever choice (ethanol/starch solution), two-bottle free choice (ethanol/water), limited access, and ethanol-deprived paradigms.  These laboratory findings are consistent with those of the herbal treatment used in China and thereby suggest that daidzin or one or more of its derivatives and/or metabolites might be effective in the treatment of alcohol abuse and/or alcoholism.

 

The mechanism by which daidzin selectively suppresses ethanol intake in laboratory animals is unknown at this time.  We have shown that daidzin is a selective and potent inhibitor of mitochondrial aldehyde dehydrogenase (ALDH-2).  ALDH-2 catalyzes the detoxification of acetaldehyde, an intermediate of ethanol metabolism.   Some humans inherit an inactive variant form of ALDH-2, and in these individuals alcohol abuse is rare.  Based on these findings, we postulated that daidzin may act by mimicking the consequences of the apparently harmless natural mutation of the ALDH-2 gene.   To evaluate this hypothesis, we synthesized a series of structural analogs of daidzin and tested and compared their ALDH-2 inhibitory activity with their antidipsotropic activity.  The results demonstrated a direct correlation between the two and raised the possibility that daidzin may, in fact, suppress ethanol intake by inhibiting ALDH-2.

 

Developmental Biology and Cellular Differentiation

 

In the course of studies of the changes in cellular composition that occur during development after the fertilization of Xenopus laevis oocytes, it became apparent that the major events that occur during this process are the result of cellular programming by critical biomolecules.  Thus, the frog requires two to three years to produce mature eggs capable of being fertilized.  In marked contrast, and evidently as a direct consequence, once fertilization takes place, a full tadpole with a complement of organs derived from all three germ lines is formed in less than 30 hours.  This means that it takes nearly 900-fold more time to mature a single-celled egg than to make an entire tadpole.  To achieve this biological feat, X. laevis oocytes must produce and store chemical signals required for differentiation and organogenesis and use them later during the period of rapid embryogenesis.   These embryo-derived differentiation factors, which we will call differins, would comprise a class of compounds that, acting singly or in combination, induce commitment of primordial or stem cells and direct them along specific differentiation paths.  X. laevis oocytes could serve as one of the systems with which to identify and isolate such substances while the embryo itself can provide the means to test their function(s).   Bioactive lipids were selected as the first class of compounds to study.